Every SEC Form 3/4/5 on record for this filer (CIK 1294596) — 6 issuers, 45 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| CYTK | CYTOKINETICS INC | Director | 2020-11-20 → 2026-05-27 | 32 | — |
| ALKS | Alkermes plc. | Director · lapsed | 2016-05-26 → 2023-07-10 | 16 | −$1M |
| PRVB | Provention Bio, Inc. | Director · lapsed | 2020-05-21 → 2023-04-27 | 6 | — |
| DOVA | Dova Pharmaceuticals Inc. | Director · lapsed | 2018-06-26 → 2019-11-12 | 5 | — |
| TTPH | TETRAPHASE PHARMACEUTICALS INC | Director · lapsed | 2016-06-10 → 2019-06-11 | 4 | — |
| INO | INOVIO PHARMACEUTICALS, INC. | Director · lapsed | 2016-05-09 → 2016-05-16 | 2 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
3 of 6 issuers are covered and open a security page; the rest are on file here only.